003020 立方制药
2025/09 - 九个月
人民币(K¥)
与去年末期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)

非流动资产
长期股权投资173,646-0.59%174,675163,95114,39820,708
投资性房地产24,242-2.38%24,83225,6172,6713,091
固定资产913,52631.84%692,904427,255182,376141,888
在建工程65,626-75.63%269,340459,661340,893130,349
无形资产101,154-3.88%105,240113,28583,38289,508
商誉74,4410.00%74,44174,44100
其他非流动资产55,908-5.32%59,04968,32345,12969,253
1,408,5440.58%1,400,4801,332,533668,850454,797

流动资产
货币资金402,570-8.44%439,694502,929642,580654,254
应收账款352,583-4.46%369,023258,447320,921282,657
存货270,07022.49%220,484242,914361,765188,857
其他流动资产163,9294.89%156,294146,856127,28193,880
1,189,1520.31%1,185,4951,151,1471,452,5471,219,648

流动负债
短期借款0--0000
应付票据0--00213,72093,677
应付帐款373,6817.53%347,525301,251246,935149,252
其他流动负债164,462-29.85%234,427241,479161,97385,125
538,143-7.53%581,952542,729622,628328,054
流动资产净值651,0097.86%603,543608,417829,919891,594
资产总额减流动负债2,059,5532.77%2,004,0231,940,9501,498,7691,346,391

非流动负债
长期借款59,640-0.02%59,65231,01400
应付债券0--0000
其他非流动负债54,46071.40%31,77336,43818,90742,480
114,10024.80%91,42467,45218,90742,480

总权益
    实收股本190,182-0.73%191,572159,675122,46792,640
    储备项目1,608,7694.04%1,546,3151,525,8511,357,3951,211,271
股东权益1,798,9513.51%1,737,8871,685,5261,479,8621,303,911
非控股权益146,502-16.15%174,712187,97200